Please ensure Javascript is enabled for purposes of website accessibility

Canada Licensed Marijuana Sales Jumped 19% in March

By Eric Volkman – May 22, 2020 at 6:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

"Stocking up" behavior helped boost dispensary revenue.

In Statistics Canada's latest monthly domestic retail sales update, the government's official numbers cruncher revealed that cannabis sales rose by 19% on a month-over-month basis in March to $181 million Canadian (US$130 million). That gain contrasted dramatically with a relatively pronounced decline in overall retail sales in the country of nearly 8% in the same timeframe.

Much of this, it has to be said, is likely due to "stocking up" behavior among cannabis consumers. March is when mandatory business shutdowns necessitated by the the SARS-CoV-2 coronavirus began in many locations, Canada included. People tended to buy large amounts of goods that would sustain or otherwise help them in the isolated circumstances dictated by stay-in-place measures.

Marijuana bud with Canadian flag in the background.

Image source: Getty Images.

That said, marijuana was one of the very few retail categories that saw a month-over-month uptick in March. Its gain was eclipsed only by that of food and beverage stores, which collectively saw a 22% increase in sales. General merchandise retailers also enjoyed gains, but these came in at under 7%.

That March sales figure for cannabis, by the way, is the largest since the country's legalization of the drug, which began in October 2018. It also reverses the latest dynamic; as February sales were nearly 2% down from the January figure.

Although they don't break out monthly sales figures as a habit, Canada's top marijuana companies surely benefited from the March rise. Nevertheless, it seems that some are finding the domestic market restrictive. On Thursday, for example, Aurora Cannabis (ACB 4.31%) announced a deal to acquire U.S.-based cannabidiol specialist Reliva. Aurora could end up paying as much as $85 million for the company.

On Friday, Aurora's shares fell by almost 8%, while the broader stock market closed the day in positive territory.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.21 (4.31%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.